Press Ganey framework puts spotlight on patient-centered care

A new report by Press Ganey presents a framework to deconstruct and address patient suffering as part of its work to advance patient-centered care.

The report, Reducing Suffering: The Path to Patient-Centered Care, advises organizations on how to understand and address sources of avoidable suffering across the patient experience. Specifically, it presents levels of advanced analytics that uncover opportunities to improve the patient experience and engagement, which are: system-level performance; individual physician performance; and employee and physician engagement.

“The industry is facing a care coordination and cost crisis,” said Patrick T. Ryan, CEO of Press Ganey. “The path to transforming our system is through patient-centered care that is designed to engage patients as active partners in their healthcare. We believe the first step on this path is to redefine our model under a new construct that identifies, understands and addresses patient suffering.” 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.